pipeline

dominoes stop stall halt end red
Biotech

Genentech drug fails rare disease study, raising obesity questions

Genentech will not push anti-myostatin antibody emugrobart into phase 3 for two muscle-wasting diseases after it failed to improve muscle growth.
Darren Incorvaia Mar 20, 2026 2:11pm
Stop sign and red lights at traffic intersection

Genentech shreds RIPK1 inhibitor after ph. 2 failure

Mar 19, 2026 2:48pm
Prune

Pfizer drops another early cancer candidate from Seagen

Mar 19, 2026 12:56pm
Eraser and chalk on a chalkboard

CNS Pharma wipes glioblastoma pipeline clean in strategic pivot

Mar 11, 2026 10:30am
divert cull another direction

Merck KGaA drops pipeline asset from SpringWorks buyout

Mar 5, 2026 4:33pm
pipeline valve pipe flow water tap

Ono’s Deciphera drops early-stage solid tumor drug

Mar 3, 2026 7:47pm